Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05174078 · ClinicalTrials.gov registry record · NA
Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management
A NA study of Obesity and Hypertension, sponsored by Cleveland Clinic Akron General.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05174078: Completed NA study of Obesity and Hypertension, sponsored by Cleveland Clinic Akron General.
NCT05174078 is a NA study of Obesity and Hypertension that has completed, run by Cleveland Clinic Akron General. The registered enrollment target is 70 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05174078, a NA study of Obesity and Hypertension, has completed, sponsored by Cleveland Clinic Akron General.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effect of providing healthy foods and nutrition education on participants' body weight, blood pressure, and average blood sugar level. The healthy food offerings tested in this study will help determine which option is best to improve health outcomes among Cleveland Clinic Akron General patients with chronic conditions. Findings from this study could guide doctors in deciding on appropriate nutrition and dietitian services for Cleveland Clinic patients.
Primary Outcome
Percent weight loss
Conditions Studied
Interventions
- OTHER Medically-tailored meals
- OTHER Produce box and recipes
Study Locations (1)
Ohio
- Cleveland Clinic Akron General - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
What the finished NCT05174078 record still lists
NCT05174078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Medically-tailored meals is the first listed.
NCT05174078 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05174078 about?
NCT05174078 is a clinical study titled "Food as Medicine: A Quasi-Randomized Control Trial of Healthy Foods for Chronic Disease Management". The purpose of this study is to investigate the effect of providing healthy foods and nutrition education on participants' body weight, blood pressure, and average blood sugar level. The healthy food offerings tested in this study will help determine which option is best to improve health outcomes ...
What is the current status of trial NCT05174078?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2022-02-01. Estimated completion is 2023-12-30.
What conditions does trial NCT05174078 study?
This clinical trial studies the following conditions: Obesity, Hypertension, Type 2 Diabetes, PreDiabetes.
What interventions are being tested in trial NCT05174078?
The interventions under investigation include: Medically-tailored meals (OTHER), Produce box and recipes (OTHER).
Who is sponsoring clinical trial NCT05174078?
This trial is sponsored by Cleveland Clinic Akron General, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05174078 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05174078's enrollment target sits among peer trials
70 595th of 1053 higher than 449 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI